Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Sebastian J C M M Neggers

1-50 of 66 results

Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study

scientific article published on 4 August 2010

Mechanisms in endocrinology: Ghrelin: the differences between acyl- and des-acyl ghrelin

scientific article published on 16 August 2012

X-linked acrogigantism syndrome: clinical profile and therapeutic responses

scientific article

Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.

scientific article published on 17 July 2015

Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly

scientific article published on 17 June 2014

Des-Acyl Ghrelin: A Metabolically Active Peptide

scientific article published on April 25, 2013

Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone

scientific article

The Metabolic Syndrome in Adult Survivors of Childhood Cancer, a Review

scientific article published on April 1, 2010

Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration W

scientific article

Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review

scientific article published on 28 July 2009

Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy

scientific article published on 22 May 2017

Medical therapy of acromegaly: efficacy and safety of somatostatin analogues

scientific article

Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study

scientific article

Combination treatment with somatostatin analogues and pegvisomant in acromegaly

scientific article

Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database.

scientific article

Abdominal Radiotherapy: A Major Determinant of Metabolic Syndrome in Nephroblastoma and Neuroblastoma Survivors

scientific article published on December 14, 2012

Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the [...]

scientific article

Long-Term Nephrotoxicity in Adult Survivors of Childhood Cancer

scientific article published on February 14, 2013

Endocrine sequelae and metabolic syndrome in adult long-term survivors of childhood acute myeloid leukemia

scientific article published on 9 January 2013

Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects

scientific article

T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly

scientific article published on 20 September 2016

Should We Consider Des-Acyl Ghrelin as a Separate Hormone and If So, What Does It Do?

scientific article published on 07 April 2014

β-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegaly.

scientific article published on 29 October 2013

Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Controlled With Pegvisomant and First-Generation Somatostatin Analogues (PAPE Study).

scientific article published on 15 November 2017

Obesity Is Underestimated Using Body Mass Index and Waist-Hip Ratio in Long-Term Adult Survivors of Childhood Cancer

scientific article published on August 14, 2012

Somatostatin analog and pegvisomant combination therapy for acromegaly

scientific article published on October 2009

Emotional Distress in 652 Dutch Very Long-term Survivors of Childhood Cancer, Using the Hospital Anxiety and Depression Scale (HADS)

scientific article published on October 1, 2013

Pituitary dysfunction after aneurysmal subarachnoid haemorrhage: course and clinical predictors—the HIPS study

scientific article published on November 6, 2014

In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas.

scientific article published on 13 March 2017

Treatment factors rather than genetic variation determine metabolic syndrome in childhood cancer survivors

scientific article published in October 2012

Combined treatment of somatostatin analogues with pegvisomant in acromegaly

scientific article published on December 10, 2015

Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs, in controlled acromegaly patients

scientific article published on September 1, 2011

Pasireotide, a multi-somatostatin receptor ligand with potential efficacy for treatment of pituitary and neuroendocrine tumors

scientific article published on February 1, 2013

Bridging the gap: metabolic and endocrine care of patients during transition

scientific article

Efficacy and Safety of switching to Pasireotide in Acromegaly Patients controlled with Pegvisomant and Somatostatin Analogues: PAPE extension study

scientific article published on 12 October 2018

What is active acromegaly and which parameters do we have?

scientific article published on May 1, 2012

Gonadal function recovery in very long-term male survivors of childhood cancer

scientific article published on January 5, 2013

Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions

scientific article published on 13 March 2018

Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study

scientific article published on June 5, 2015

A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues.

scientific article

Diagnostic value of a ghrelin test for the diagnosis of GH deficiency after subarachnoid hemorrhage

scientific article published on September 14, 2013

Pegvisomant in combination with long-acting somatostatin analogues in acromegaly: the role of the GH receptor deletion of exon 3

scientific article published on August 4, 2015

Pegvisomant Treatment in Acromegaly

scientific article published on March 19, 2015

Very long-term sequelae of craniopharyngioma.

scientific article

The limited screening value of insulin‐like growth factor‐i as a marker for alterations in body composition in very long‐term adult survivors of childhood cancer

scientific article published on December 11, 2011

Modulation of Glucocorticoid Metabolism by the GH-IGF-I Axis

scientific article published on December 16, 2010

Risk factors for subsequent endocrine-related cancer in childhood cancer survivors

scientific article

Adrenal function in adult long-term survivors of nephroblastoma and neuroblastoma

scientific article published on April 16, 2012

Pasireotide responsiveness in acromegaly is mainly driven by somatostatin receptor subtype 2 expression

scientific article published on 01 March 2019

In active acromegaly, IGF1 bioactivity is related to soluble Klotho levels and quality of life

scientific article published on April 15, 2014